Harmony Biosciences Management, Inc.
Clinical trials sponsored by Harmony Biosciences Management, Inc., explained in plain language.
-
Sleep disorder drug gets extended safety check
Disease control CompletedThis study followed adults with idiopathic hypersomnia, a rare disorder causing extreme daytime sleepiness, to see how safe and effective the medication pitolisant is over the long term. All 119 participants had already completed a previous pitolisant study and continued taking t…
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
CBD gel tested to calm anxiety in kids with rare genetic disorder
Symptom relief CompletedThis study tested whether a cannabidiol (CBD) gel applied to the skin is safe and helpful for children and teenagers with 22q11.2 deletion syndrome. The goal was to see if the gel could ease anxiety and improve difficult behaviors. About 20 participants, aged 4 to 18, used the ge…
Phase: PHASE2 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New narcolepsy pill tested for side effects
Symptom relief CompletedThis study tested how well adults with narcolepsy tolerated a new, delayed-release version of a medication called pitolisant. The goal was to see if starting at the full treatment dose caused too many side effects or led people to stop taking it. Researchers monitored 46 particip…
Phase: PHASE1 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Mar 19, 2026 14:56 UTC
-
Scientists test skin Gel's hidden effects on common pills
Knowledge-focused CompletedThis study aimed to understand how a gel applied to the skin, called ZYN002, might change how the body processes other common medications. Researchers gave healthy adult volunteers several standard drugs and measured their levels in the blood and urine before and after using the …
Phase: PHASE1 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC